WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522501
Description: BMS-795311 is a potent CETP inhibitor that maximally inhibited cholesteryl ester (CE) transfer activity at an oral dose of 1 mg/kg in human ETP/apoB-100 dual transgenic mice and increased HDL cholesterol content and size comparable to torcetrapib in moderately-fat fed hamsters. Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that is responsible for transporting neutral lipids such as cholesteryl esters (CEs) and triglycerides (TGs) among various classes of lipoproteins including HDL, LDL, and very low density lipoprotein (VLDL).2 Physiologically, CETP facilitates the transfer of CE from HDL to LDL and VLDL in exchange for TG, leading to decreased HDL-C levels and increased LDL-C levels.
MedKoo Cat#: 522501
Chemical Formula: C34H23F10NO3
Exact Mass: 683.15183
Molecular Weight: 683.54603
Elemental Analysis: C, 59.74; H, 3.39; F, 27.79; N, 2.05; O, 7.02
BMS-795311, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.
Synonym: BMS-795311; BMS 795311; BMS795311.
IUPAC/Chemical Name: (R)-N-(1-(3-cyclopropoxy-4-fluorophenyl)-1-(3-fluoro-5-(2,2,3,3-tetrafluoropropanoyl)phenyl)-2-phenylethyl)-4-fluoro-3-(trifluoromethyl)benzamide
InChi Key: VHVGQTQWTDTENQ-JGCGQSQUSA-N
InChi Code: InChI=1S/C34H23F10NO3/c35-23-13-20(29(46)33(40,41)31(38)39)12-22(15-23)32(17-18-4-2-1-3-5-18,21-7-11-27(37)28(16-21)48-24-8-9-24)45-30(47)19-6-10-26(36)25(14-19)34(42,43)44/h1-7,10-16,24,31H,8-9,17H2,(H,45,47)/t32-/m1/s1
SMILES Code: FC1=CC=C(C=C1OC2CC2)[C@](CC3=CC=CC=C3)(C4=CC(C(C(C(F)F)(F)F)=O)=CC(F)=C4)NC(C5=CC(C(F)(F)F)=C(C=C5)F)=O
The following data is based on the product molecular weight 683.54603 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Qiao JX, Wang TC, Adam LP, Chen AY, Taylor DS, Yang RZ, Zhuang S, Sleph PG, Li JP, Li D, Yin X, Chang M, Chen XQ, Shen H, Li J, Smith D, Wu DR, Leith L, Harikrishnan LS, Kamau MG, Miller MM, Bilder D, Rampulla R, Li YX, Xu C, Lawrence RM, Poss MA, Levesque P, Gordon DA, Huang CS, Finlay HJ, Wexler RR, Salvati ME. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311). J Med Chem. 2015 Nov 17. [Epub ahead of print] PubMed PMID: 26524347.